Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

775 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Outcomes of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients with COVID-19: CASCADE Initiative.
Sasanejad P, Afshar Hezarkhani L, Arsang-Jang S, Tsivgoulis G, Ghoreishi A, Barlinn K, Rahmig J, Farhoudi M, Sadeghi Hokmabadi E, Borhani-Haghighi A, Sariaslani P, Sharifi-Razavi A, Ghandehari K, Khosravi A, Smith C, Nilanont Y, Akbari Y, Nguyen TN, Bersano A, Yassi N, Yoshimoto T, Lattanzi S, Gupta A, Zand R, Rafie S, Pourandokht Mousavian S, Reza Shahsavaripour M, Amini S, Kamenova SU, Kondybayeva A, Zhanuzakov M, Macri EM, Nobleza COS, Ruland S, Cervantes-Arslanian AM, Desai MJ, Ranta A, Moghadam Ahmadi A, Rostamihosseinkhani M, Foroughi R, Hooshmandi E, Akhoundi FH, Shuaib A, Liebeskind DS, Siegler J, Romano JG, Mayer SA, Bavarsad Shahripour R, Zamani B, Woolsey A, Fazli Y, Mojtaba K, Isaac CF, Biller J, Di Napoli M, Azarpazhooh MR. Sasanejad P, et al. Among authors: amini s. J Stroke Cerebrovasc Dis. 2021 Dec;30(12):106121. doi: 10.1016/j.jstrokecerebrovasdis.2021.106121. Epub 2021 Sep 20. J Stroke Cerebrovasc Dis. 2021. PMID: 34601242 Free PMC article.
Efficacy and safety of convalescent plasma therapy in severe COVID-19 patients with acute respiratory distress syndrome.
Allahyari A, Seddigh-Shamsi M, Mahmoudi M, Amel Jamehdar S, Amini M, Mozdourian M, Javidarabshahi Z, Eslami Hasan Abadi S, Amini S, Sedaghat A, Emadzadeh M, Moeini Nodeh M, Rahimi H, Bari A, Mozaheb Z, Kamandi M, Ataei Azimi S, Abrishami M, Akbarian A, Ataei P, Allahyari N, Hasanzadeh S, Saeedian N. Allahyari A, et al. Among authors: amini m, amini s. Int Immunopharmacol. 2021 Apr;93:107239. doi: 10.1016/j.intimp.2020.107239. Epub 2020 Dec 2. Int Immunopharmacol. 2021. PMID: 33582019 Free PMC article. Clinical Trial.
METHYLENE BLUE FOR TREATMENT OF HOSPITALIZED COVID-19 PATIENTS: A RANDOMIZED, CONTROLLED, OPEN-LABEL CLINICAL TRIAL, PHASE 2.
Hamidi-Alamdari D, Hafizi-Lotfabadi S, Bagheri-Moghaddam A, Safari H, Mozdourian M, Javidarabshahi Z, Peivandi-Yazdi A, Ali-Zeraati A, Sedaghat A, Poursadegh F, Barazandeh-Ahmadabadi F, Agheli-Rad M, Tavousi SM, Vojouhi S, Amini S, Amini M, Majid-Hosseini S, Tavanaee-Sani A, Ghiabi A, Nabavi-Mahalli S, Morovatdar N, Rajabi O, Koliakos G. Hamidi-Alamdari D, et al. Among authors: amini m, amini s. Rev Invest Clin. 2021;73(3):190-198. doi: 10.24875/RIC.21000028. Rev Invest Clin. 2021. PMID: 34019535 Free article. Clinical Trial.
Ocular Manifestations of Hospitalized Patients with COVID-19 in Northeast of Iran.
Abrishami M, Tohidinezhad F, Daneshvar R, Omidtabrizi A, Amini M, Sedaghat A, Amini S, Reihani H, Allahyari A, Seddigh-Shamsi M, Tayyebi M, Naderi H, Bojdy A, Khodashahi R, Eslami S. Abrishami M, et al. Among authors: amini m, amini s. Ocul Immunol Inflamm. 2020 Jul 3;28(5):739-744. doi: 10.1080/09273948.2020.1773868. Epub 2020 Jun 22. Ocul Immunol Inflamm. 2020. PMID: 32569494
775 results